News

Prescription opioids linked to majority of opioid overdoses


 

FROM JAMA INTERNAL MEDICINE

References

More than two-thirds of all opioid overdoses presenting to U.S. emergency departments in 2010 involved prescription opioids, according to a study published online Oct. 27 in JAMA Internal Medicine.

Of the 135,971 ED visits for opioid overdoses identified, 67.8% involved a prescription opioid (including methadone), 16.1% involved heroin, 13.4% involved unspecified opioids, and 2.7% involved multiple types of opioids, said Michael A. Yokell of Stanford (Calif.) University and his associates (JAMA Intern. Med. 2014 Oct. 27 [doi:10.1001/jamainternmed2014.5413]).

[DW] Opioid overdoses in the ED: Visits by region, inpatient costs

The analysis also showed “marked regional variation in overdose patterns, with the highest burdens of prescription overdose found in the South and West,” the investigators said.

The mean charge for inpatient stays for all overdoses was more than $29,800, with a mean length of stay of 3.8 days. The total cost for all inpatient stays was $2.05 billion, with $1.25 billion going for visits involving prescription opioids and an additional $267 million for visits involving methadone. ED visits involving heroin cost $151 million and visits involving unspecified or multiple opioid types cost $375 million, according to data from the 2010 Nationwide Emergency Department Sample.

The study was funded by Stanford University and by grants from the Centers for Disease Control and Prevention; the National Institutes of Health; and the National Heart, Lung, and Blood Institute. One of the investigators reported employment in the past year with Inflexxion. No other disclosures were reported.

r.franki@frontlinemedcom.com

Recommended Reading

VIDEO: Primary care docs don’t use risk reduction strategies, for so many reasons
MDedge Neurology
VIDEO: Risks of long-term opioid use remain unstudied
MDedge Neurology
Take-home naloxone expands to chronic pain patients on opioids
MDedge Neurology
Curbing opioid abuse could be a quality of care issue
MDedge Neurology
Handheld vagal nerve stimulator reduced cluster headache attacks
MDedge Neurology
VIDEO: What’s on the horizon for headaches
MDedge Neurology
Amitriptyline beat pregabalin for chronic low back pain
MDedge Neurology
Study finds few data on long-term opioid treatment for chronic pain
MDedge Neurology
FDA approves new abuse-prevention labeling for extended-release Embeda
MDedge Neurology
ACR 2010 criteria for fibromyalgia critiqued
MDedge Neurology